A machine learning model analyzing cardiac MRI and clinical data outperformed established risk scores for predicting long-term STEMI outcomes.
Key Details
- 1New ML model predicts major adverse cardiovascular events (MACE) in STEMI patients using cardiac MRI and clinical parameters.
- 2The model demonstrated excellent predictive performance and discrimination in external validation.
- 3Outperformed traditional risk models including the Global Registry of Acute Coronary Events and Thrombolysis in Myocardial Infarction scores.
- 4Led by radiology researchers at Renji Hospital, China.
- 5Findings published in Radiology.
Why It Matters
This work shows the power of combining MRI imaging and AI for better patient-specific risk prediction, which may help clinicians improve management of high-risk STEMI patients. It moves risk assessment in cardiology toward a more personalized, imaging-driven approach.
Source
Cardiovascular Business
Related News
•Radiology Business
Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.
•AuntMinnie
AI Models Reveal Racial Disparities in Breast Cancer Patterns
Machine learning models reveal significant racial disparities and key predictors in breast cancer incidence across diverse groups.
•AuntMinnie
AI Algorithm Streamlines and Standardizes Shoulder Ultrasound Acquisition
A multitask AI system demonstrated high accuracy in standardizing and guiding shoulder musculoskeletal ultrasound imaging.